Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study
- PMID: 33234342
- DOI: 10.1016/j.clnu.2020.10.058
Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study
Abstract
Background and aims: We assessed the association of Mediterranean diet with NAFLD and their interaction in predicting ten-year diabetes onset and first fatal/non-fatal cardiovascular disease (CVD) incidence.
Methods: The ATTICA prospective observational study in Athens, Greece included 1,514 men and 1,528 women (>18 years old) free-of-CVD at baseline. Liver steatosis and fibrosis indices were calculated. Mediterranean diet adherence was assessed through MedDietScore. At the ten-year follow-up visit, CVD evaluation was performed in an a priori specified subgroup of n = 2,020 participants and diabetes onset in n = 1,485 free-of-diabetes participants.
Results: MedDietScore was inversely associated with steatosis and fibrosis; e.g. in the case of the TyG index the Odds Ratio (OR) of the 3rd vs. 1st MedDietScore tertile was = 0·53, [95% Confidence Interval (95% CI) (0·29, 0·95)] and the associations persisted in multi-adjusted models. NAFLD predicted incident diabetes prospectively over a ten year period [HR = 1·87, 95% CI (0·75, 4·61)] and the association remained significant only in subjects with low MedDietScore (below median) whereas diabetes onset among subjects with higher MedDietScore was not influenced by NAFLD. Similarly, NAFLD predicted CVD [Hazard Ratio (HR) = 3·01, 95%CI(2·28, 3·95)]; the effect remained significant only in subjects with MedDietScore below median [HR = 1·38, 95% CI (1·00, 1·93)] whereas it was essentially null [HR = 1·00,95% CI (0·38, 2·63)] among subjects with higher score. Mediation analysis revealed that adiponectin and adiponectin-to-leptin ratio were the strongest mediators.
Conclusions: We report an inverse association between Mediterranean diet and NAFLD. Mediterranean diet protected against diabetes and CVD prospectively among subjects with NAFLD.
Keywords: Adipocytokines; Liver fibrosis; Liver steatosis; Macronutrients; Nutrition.
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Conflict of interest statement
Conflict of interest See funding below. The rest of the authors declare no conflicts of interest.
Similar articles
-
Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).Nutrients. 2022 Jun 7;14(12):2367. doi: 10.3390/nu14122367. Nutrients. 2022. PMID: 35745097 Free PMC article.
-
Mediterranean Diet and 10-year (2002-2012) Incidence of Diabetes and Cardiovascular Disease in Participants with Prediabetes: The ATTICA study.Rev Diabet Stud. 2016 Winter;13(4):226-235. doi: 10.1900/RDS.2016.13.226. Epub 2017 Feb 10. Rev Diabet Stud. 2016. PMID: 28278309 Free PMC article.
-
Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.Clin Nutr. 2022 Jun;41(6):1281-1289. doi: 10.1016/j.clnu.2022.03.022. Epub 2022 Mar 31. Clin Nutr. 2022. PMID: 35504171
-
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.Diabetes Metab J. 2020 Jun;44(3):382-401. doi: 10.4093/dmj.2020.0010. Epub 2020 May 11. Diabetes Metab J. 2020. PMID: 32431115 Free PMC article. Review.
-
Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis.Liver Int. 2019 Mar;39(3):557-567. doi: 10.1111/liv.13994. Epub 2018 Dec 4. Liver Int. 2019. PMID: 30358050
Cited by
-
The effectiveness of magnetic resonance imaging (MRI) iron corrected T1 in monitoring metabolic dysfunction-associated steatohepatitis in obesity following bariatric surgery and lifestyle modification: a prospective cohort study.Quant Imaging Med Surg. 2024 Jul 1;14(7):4659-4674. doi: 10.21037/qims-24-148. Epub 2024 May 24. Quant Imaging Med Surg. 2024. PMID: 39022255 Free PMC article.
-
Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.Int J Mol Sci. 2025 Jun 14;26(12):5717. doi: 10.3390/ijms26125717. Int J Mol Sci. 2025. PMID: 40565181 Free PMC article. Review.
-
Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?Antioxidants (Basel). 2024 Jun 16;13(6):731. doi: 10.3390/antiox13060731. Antioxidants (Basel). 2024. PMID: 38929170 Free PMC article. Review.
-
Relationship between the Mediterranean diet and risk of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A cross-sectional analysis of the RaNCD cohort.Front Nutr. 2023 Feb 22;10:1062008. doi: 10.3389/fnut.2023.1062008. eCollection 2023. Front Nutr. 2023. PMID: 36908910 Free PMC article.
-
Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction.Front Cardiovasc Med. 2023 Jan 12;9:1120085. doi: 10.3389/fcvm.2022.1120085. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36712249 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical